Relationship of uveal and cutaneous malignant melanoma in persons with multiple primary tumors

International Journal of Cancer

Volumn 102, Issue 3, 2002, Pages 266-268

  Shors, Andrew R ^a   Iwamoto, Satori ^a   Doody, David R ^b   Weiss, Noel S ^b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cutaneous melanoma; Second cancer; SEER; Uveal melanoma

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; MULTIPLE CANCER; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SECOND CANCER; UVEA TUMOR;

EID: 0037145723     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10703     Document Type: Article

References (40)

1. Scotto J, Fraumeni JF Jr. Lee JA. Melanomas of the eye and other noncutaneous sites: Epidemiologic aspects. J Natl Cancer Inst 1976;56:489-91.
2. Strickland D, Lee JA. Melanomas of eye: Stability of rates. Am J Epidemiol 1981;113:700-2.
3. Holly EA, Aston DA, Char DH, Kristiansen JJ, Ahn DK. Uveal melanoma in relation to ultraviolet light exposure and host factors. Cancer Res 1990;50:5773-7.
4. Guenel P, Laforest L, Cyr D, Fevotte J, Sabroe S, Dufour C, Lutz JM, Lynge E. Occupational risk factors, ultraviolet radiation, and ocular melanoma: A case-control study in France. Cancer Causes Control 2001;12:451-9.
5. Gallagher RP, Elwood JM, Rootman J, Spinelli JJ, Hill GB, Threlfall WJ, Birdsell JM. Risk factors for ocular melanoma: Western Canada melanoma study. J Natl Cancer Inst 1985:74:775-8.
6. Vajdic CM, Kricker A, Giblin M, McKenzie J, Aitken J, Giles GG, Armstrong BK. Eye color and cutaneous nevi predict risk of ocular melanoma in Australia. Int J Cancer 2001;92:906-12.
7. Schwartz SM, Weiss NS. Place of birth and incidence of ocular melanoma in the United States. Int J Cancer 1988;41:174-7.
8. Raivio I. Uveal melanoma in Finland. An epidemiological, clinical, histological prognostic study. Acta Ophthalmol 1977;133(suppl):1-64.
9. Teikari JM, Raivio I. Incidence of choroidal malignant melanoma in Finland in the years 1973-1980. Acta Ophthalmol (Copenh) 1985;63:661-5.
10. Didolkar MS, Elias EG, Barber NA, Moore RH. Biologic behavior of ocular malignant melanoma and comparison with melanoma of the head and neck. Am J Surg 1980;140:522-6.
11. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer. Cancer 1998;83:1664-78.
12. Iwamoto S, Burrows RC, Agoff SN, Piepkorn M, Bothwell M, Schmidt R. The p75 neurotrophin receptor, relative to other Schwann cell and melanoma markers, is abundantly expressed in spindled melanomas. Am J Dermatopathol 2001:23:288-94.
13. Iwamoto S, Burrows RC, Kalina RE. George D, Boehm M, Bothwell MA, Schmidt R. Immunophenotypic differences between uveal and cutaneous melanomas. Arch Ophthalmol 2002;120:466-70.
14. Iwamoto S, Burrows RC, Grossniklaus H, Kalina RE, Boehm M, Bothwell MA, Schmidt R. Immunophenotypic expression pattern of conjunctival melanomas. Arch Ophthalmol, in press.
15. Elwood JM, Gallagher RP, Worth AJ, Wood WS, Pearson JC. Etiological differences between subtypes of cutaneous malignant melanoma: Western Canada melanoma study. J Natl Cancer Inst 1987;78:37-44.
16. Swerlick RA, Chen S. The melanoma epidemic. Is increased surveillance the solution or the problem? Arch Dermatol 1996;132:881-4.
17. Boice JD Jr, Storm HH, Curtis RE, Jensen OM, Kleinerman RA, Jensen HS, Flannery JT, Fraumeni JF Jr. Introduction to the study of multiple primary cancers. Natl Cancer Inst Monogr 1985;68:3-9.
18. Ramaesh K, Marshall JW, Wharton SB, Dhillon B. Intraocular metastases of cutaneous malignant melanoma: A case report and review of the literature. Eye 1999;13(Pt 2):247-50.
19. Bataille V, Pinney E, Hungerford JL, Cuzick J, Bishop DT. Newton JA. Five cases of coexistent primary ocular and cutaneous melanoma. Arch Dermatol 1993;129:198-201.
20. Abramson DH, Servodidio CA. A case of primary choroidal melanoma in a patient with previous melanoma. Arch Ophthalmol 1997;115:1606.
21. Bellet RE, Vaisman 1, Mastrangelo MJ, Lustbader E. Multiple primary malignancies in patients with cutaneous melanoma. Cancer 1977;40(suppl):1974-81.
22. Albert DM, Chang MA, Lamping K, Weiter J, Sober A. The dysplastic nevus syndrome. A pedigree with primary malignant melanomas of the choroid and skin. Ophthalmology 1985;92:1728-34.
23. van Hees CL, Jager MJ, Bleeker JC, Kemme H, Bergman W. Occurrence of cutaneous and uveal melanoma in patients with uveal melanoma and their first degree relatives. Melanoma Res 1998;8:175-80.
24. Singh AD, Wang MX, Donoso LA, Shields CL, De Potter F, Shields JA. Genetic aspects of uveal melanoma: A brief review. Semin in Oncol 1996;23:768-72.
25. Greene MH, Sanders RJ, Chu FC. Clark WH Jr, Elder DE, Cogan DG. The familial occurrence of cutaneous melanoma, intraocular melanoma, and the dysplastic nevus syndrome. Am J Ophthalmol 1983;96:238-45.
26. Cannon-Albright LA, Goldgar DE, Meyer LJ, Lewis CM, Anderson DE, Fountain JW, Hegi ME, Wiseman RW, Petty EM, Bale AE, Olopade OI, Diaz MO, et al. Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22, Science 1992;258:1148-52.
27. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheahan MD, Clark WH Jr, Tucker MA, Dracopoli NC. Germline p16 mutations in familial melanoma. Nat Genet 1994;8:15-21.
28. Ohta M, Nagai H, Shimizu M, Rasio D, Berd D, Mastrangelo M, Singh AD, Shields JA, Shields CL, Croce CM, Huebner K. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK41, in melanoma. Cancer Res 1994;54:5269-72.
29. Wang X, Egan KM, Gragoudas ES, Kelsey KT. Constitutional alterations in p16 in patients with uveal melanoma. Melanoma Res 1996;6:405-10.
30. Armstrong BK, English DR. Cutaneous malignant melanoma In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention. New York: Oxford University Press, 1996. 1282-312.
31. Tucker MA, Shields JA, Hartge P, Augsburger J, Hoover RN, Fraumeni JF Jr. Sunlight exposure as risk factor for intraocular malignant melanoma. N Engl J Med 1985;313:789-92.
32. Mooy CM, Van der Helm MJ. Van der Kwast TH, De Jong PT, Ruiter DJ, Zwarthoff EC. No N-ras mutations in human uveal melanoma: The role of ultraviolet light revisited. Br J Cancer 1991;64:411-3.
33. van Hees CL, de Boer A, Jager MJ, Bleeker JC, Kakebeeke HM, Crijns MB, Vandenbroucke JP, Bergman W. Are atypical nevi a risk factor for uveal melanoma? A case-control study. J Invest Dermatol 1994;103:202-5.
34. Taylor MR, Guerry DT, Bondi EE. Shields JA, Augsburger JJ, Lusk EJ, Elder DE, Clark WH Jr. Van Horn M. Lack of association between intraocular melanoma and cutaneous dysplastic nevi. Am J Ophthalmol 1984;98:478-82.
35. Bliss JM, Ford D, Swerdlow AJ, Armstrong BK, Cristofolini M, Elwood JM, Green A, Holly EA, Mack T, MacKie RM, Osterlind A, Walter SD, et al. Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: Systematic overview of 10 case-control studies. The International Melanoma Analysis Group (IMAGE). Int J Cancer 1995;62:367-76.
36. Turner BJ, Siatkowski RM, Augsburger JJ, Shields JA, Lustbader E, Mastrangelo MJ. Other cancers in uveal melanoma patients and their families. Am J Ophthalmol 1989;107:601-8.
37. Tucker MA, Boice JD Jr, Hoffman DA. Second cancer following cutaneous melanoma and cancers of the brain, thyroid, ccnnective tissue, bone, and eye in Connecticut, 1935-82. Natl Cancer Inst Monogr 1985;68:161-89.
38. Swerdlow AJ, Storm HH, Sasieni PD. Risks of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943-1989. Int J Cancer 1995;61:773-9.
39. Holly EA, Aston DA, Ahn DK, Kristiansen JJ, Char DH. No excess prior cancer in patients with uveal melanoma. Ophthalmology 1991;98:608-11.
40. Lischko AM, Seddon JM, Gragoudas ES, Egan KM, Glynn RJ. Evaluation of prior primary malignancy as a determinant of uveal. A case-control study. Ophthalmology 1989;96:1716-21.